Dermatology Doctors in Stateline, NV Accepting Medicare

3 Dermatology doctors found. Showing 1 - 3

Miss Lauren Michelle Lee, RPAC Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 276 Kingsbury Grade Ste 101, Stateline, NV 89449 Phone: 775-588-5000

Martin Ernst Salm, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 276 Kingsbury Grade, Suite 101, Stateline, NV 89449 Phone: 775-588-5000    Fax: 775-588-5001

Dr. Benjamin Daniel Bradford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 276 Kingsbury Grade # 101, Stateline, NV 89449 Phone: 775-588-5000

News Archive

State highlights: N.Y. hospitals scramble to sign uninsured up for care; N.C. lawmakers debate Medicaid; Ore. data questions immigrant 'burden' on Medicaid

Many of [New York City's] financially strapped hospitals are scrambling to sign up people for health coverage through New York state's exchange or through Medicaid as they brace for federal cuts to providers of so-called charity care for the uninsured. At Montefiore Medical Center in the Bronx, the staff is posting insurance information on social-networking websites and giving presentations at churches and mosques. At Maimonides Medical Center in Brooklyn, officials have met with the Brooklyn Chamber of Commerce to ensure small businesses know their insurance options. Some hospitals are recruiting patients for coverage plans in emergency-room lobbies (Dawsey, 11/20).

Few veterans seek review of disability rating, panel finds

"Only a small fraction of wounded veterans who could get better benefits have applied in the two years since Congress, acting on concerns the military was cutting costs by downplaying injuries, ordered the Pentagon to review disputed claims," The Associated Press reports.

Debiopharm granted license to develop and commercialise CDC25

Ipsen, an innovation-driven global specialty pharmaceutical Group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced today the signature of an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen's first-in-class inhibitor of the CDC25 phosphatase enzyme (now Debio 0931), for the treatment of various human cancers.

Alcoholism in Hispanics dependent on gene/environment interaction

Hispanics with alcohol-induced problems - especially male Mexican Americans - have significantly worse health and welfare than those with other ethnic backgrounds. This study examined the influence of gene/environment interaction on alcoholism among Mexican Americans. Researchers have found that interaction between education and a polymorphism of the reward gene contribute to severe alcoholism among Mexican Americans.

Read more Medical News

› Verified 2 days ago